WordNet

any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)
an abnormal new mass of tissue that serves no purpose (同)tumour, neoplasm

PrepTutorEJDIC

抗原(生物の体内にはいって免疫体を作る物質)

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/03/21 14:10:25」(JST)

wiki en

[Wiki en表示]

Tumor antigen is an antigenic substance produced in tumor cells, i.e., it triggers an immune response in the host. Tumor antigens are useful tumor markers in identifying tumor cells with diagnostic tests and are potential candidates for use in cancer therapy. The field of cancer immunology studies such topics.

Mechanism of tumor antigenesis[edit]

Normal proteins in the body are not antigenic because of self-tolerance, a process in which self-reacting cytotoxic T lymphocytes (CTLs) and autoantibody-producing B lymphocytes are culled "centrally" in primary lymphatic tissue (BM) and "peripherally" in secondary lymphatic tissue (mostly thymus for T-cells and spleen/lymph nodes for B cells). Thus any protein that is not exposed to the immune system triggers an immune response. This may include normal proteins that are well sequestered from the immune system, proteins that are normally produced in extremely small quantities, proteins that are normally produced only in certain stages of development, or proteins whose structure is modified due to mutation.

Classification of tumor antigens[edit]

Initially tumor antigens were broadly classified into two categories based on their pattern of expression: Tumor-Specific Antigens (TSA), which are present only on tumor cells and not on any other cell and Tumor-Associated Antigens (TAA), which are present on some tumor cells and also some normal cells.

This classification, however,is imperfect because many antigens thought to be tumor-specific turned out to be expressed on some normal cells as well. The modern classification of tumor antigens is based on their molecular structure and source.

Accordingly they can be classified as;^{[citation needed]}

Products of Mutated Oncogenes and Tumor Suppressor Genes
Products of Other Mutated Genes
- Overexpressed or Aberrantly Expressed Cellular Proteins
- Tumor Antigens Produced by Oncogenic Viruses
- Oncofetal Antigens
- Altered Cell Surface Glycolipids and Glycoproteins
- Cell Type-Specific Differentiation Antigens

Types[edit]

Any protein produced in a tumor cell that has an abnormal structure due to mutation can act as a tumor antigen. Such abnormal proteins are produced due to mutation of the concerned gene. Mutation of protooncogenes and tumor suppressors which lead to abnormal protein production are the cause of the tumor and thus such abnormal proteins are called tumor-specific antigens. Examples of tumor-specific antigens include the abnormal products of ras and p53 genes. In contrast, mutation of other genes unrelated to the tumor formation may lead to synthesis of abnormal proteins which are called tumor-associated antigens.

Proteins that are normally produced in very low quantities but whose production is dramatically increased in tumor cells, trigger an immune response. An example of such a protein is the enzyme tyrosinase, which is required for melanin production. Normally tyrosinase is produced in minute quantities but its levels are very much elevated in melanoma cells.

Oncofetal antigens are another important class of tumor antigens. Examples are alphafetoprotein (AFP) and carcinoembryonic antigen (CEA). These proteins are normally produced in the early stages of embryonic development and disappear by the time the immune system is fully developed. Thus self-tolerance does not develop against these antigens.

Abnormal proteins are also produced by cells infected with oncoviruses, e.g. EBV and HPV. Cells infected by these viruses contain latent viral DNA which is transcribed and the resulting protein produces an immune response.

In addition to proteins, other substances like cell surface glycolipids and glycoproteins may also have an abnormal structure in tumor cells and could thus be targets of the immune system.

Importance of tumor antigens[edit]

Tumor antigens, because of their relative abundance in tumor cells are useful in identifying specific tumor cells. Certain tumors have certain tumor antigens in abundance.

Tumor antigen	Tumor in which it is found	Remarks
Alphafetoprotein (AFP)	Germ cell tumors Hepatocellular carcinoma
Carcinoembryonic antigen (CEA)	bowel cancers	Occasional lung or breast cancer
CA-125	Ovarian cancer
MUC-1	breast cancer
Epithelial tumor antigen (ETA)	Breast cancer
Tyrosinase	Malignant melanoma	normally present in minute quantities; greatly elevated levels in melanoma
Melanoma-associated antigen (MAGE)	malignant melanoma	Also normally present in the testis
abnormal products of ras, p53	Various tumors

Certain tumor antigens are thus used as tumor markers. More importantly, tumor antigens can be used in cancer therapy as tumor antigen vaccines.^[1]

References[edit]

^ M Hareuveni, C Gautier, M Kieny, D Wreschner, P Chambon and R Lathe; Vaccination Against Tumor Cells Expressing Breast Cancer Epithelial Tumor Antigen; Proceedings of the National Academy of Sciences, Vol 87, 9498-9502, 1990.

Kumar, Abbas, Fausto; Robbins and Cotran: Pathologic Basis of Disease; Elsevier, 7th ed.
Coulie PG, Hanagiri T, Takanoyama M: From Tumor Antigens to Immunotherapy. Int J Clin Oncol 6:163, 2001.

External links[edit]

Chapter on tumor antigens in Cancer Medicine at NCBI

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 造血細胞移植後の移植片対腫瘍効果の生物学 biology of the graft versus tumor effect following hematopoietic cell transplantation
2. 転移性乳癌の全身治療：一般原則 systemic treatment for metastatic breast cancer general principles
3. 前立腺癌のスクリーニング screening for prostate cancer
4. 消化器における神経内分泌腫瘍の発生の病理、分類、および重症度分類 pathology classification and grading of neuroendocrine tumors arising in the digestive system
5. 十二指腸乳頭部癌：疫学、臨床症状、診断および病期分類 ampullary carcinoma epidemiology clinical manifestations diagnosis and staging

English Journal

Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.

Wu M1,2, Zhao H3, Guo L1, Wang Y1, Song J4, Zhao X5, Li C6, Hao L7, Wang D8, Tang J1.
Drug delivery.Drug Deliv.2018 Nov;25(1):226-240. doi: 10.1080/10717544.2017.1422300.
PMID 29313393

Perylenetetracarboxylic acid and carbon quantum dots assembled synergistic electrochemiluminescence nanomaterial for ultra-sensitive carcinoembryonic antigen detection.

Xu LL1, Zhang W2, Shang L1, Ma RN1, Jia LP1, Jia WL1, Wang HS3, Niu L4.
Biosensors & bioelectronics.Biosens Bioelectron.2018 Apr 30;103:6-11. doi: 10.1016/j.bios.2017.10.035. Epub 2017 Oct 17.
PMID 29275222

Spatial-resolved dual-signal-output electrochemiluminescent ratiometric strategy for accurate and sensitive immunoassay.

Wang YL1, Liu FR1, Cao JT2, Ren SW3, Liu YM4.
Biosensors & bioelectronics.Biosens Bioelectron.2018 Apr 15;102:525-530. doi: 10.1016/j.bios.2017.11.067. Epub 2017 Dec 1.
PMID 29202438

Japanese Journal

腫瘍マーカーからの診断 (特集大腸癌の最新治療 : 治癒に向けた最先端研究) -- (臨床研究)

風間伸介,渡邉聡明
日本臨床 72(1), 71-76, 2014-01
NAID 40019920552

High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer

Chen Xiaohui,Song Ning,Matsumoto Keitaro,Nanashima Atsushi,Nagayasu Takeshi,Hayashi Tomayoshi,Ying Mingang,Endo Daisuke,Wu Zhiren,Koji Takehiko
International Journal of Oncology 43(5), 1467-1480, 2013-11
… Global histone modification patterns have been implicated as possible predictors of cancer recurrence and prognoses in a great variety of tumor entities. … The expression of H3K27me3 and its methyltransferase, enhancer of zeste homolog 2 (EZH2) together with proliferating cell nuclear antigen (PCNA) were evaluated by immunohistochemistry in normal lung tissue (n=5) and resected NSCLC patients (n=42). …
NAID 120005372480

集学的治療により良好に経過している転移性前立腺癌肉腫の1例

松岡崇志,杉野善雄,小林恭,寺田直樹,山崎俊成,松井喜之,今村正明,大久保和俊,神波大己,吉村耕治,小川修
泌尿器科紀要 59(11), 749-752, 2013-11
… A 58-year-old man was referred to our hospital with dysuria and elevation of prostate specific antigen (38.0 ng/ml). … The tumor had extended to the rectum and metastasized to bilateral obturator lymph nodes and right ischial bone (cT4N1M1b). …
NAID 120005350248